Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas.
published in: Cancer Immunology, Immunotherapy
date of publication: 2012-11-10
Cites articles 33
- 2009-01-01
- 2009-05-01
- 2006-01-01
Date
Title
Article - wd:Q45988106